VOR CIK: 1817229

Vor Biopharma Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.21
FY22:
0.24
FY23:
0.14
FY24:
0.10
FY25:
0.46
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.06
FY23:
0.06
FY24:
0.05
FY25:
0.01
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.24
FY22:
0.30
FY23:
0.20
FY24:
0.14
FY25:
0.46

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.01
FY23:
0.02
FY24:
0.02
FY25:
0.03
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.04
FY23:
0.03
FY24:
0.03
FY25:
0.60
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.22
FY22:
0.25
FY23:
0.15
FY24:
0.10
FY25:
−0.16
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.24
FY22:
0.30
FY23:
0.20
FY24:
0.14
FY25:
0.46

All amounts in billions USD Data source:SEC EDGAR